Initiation Archives - Page 147 of 272

1 minute read

Chardan Capital Initiates Coverage On Dragonfly Energy Hldgs with Buy Rating, Announces Price Target of $15

November 18, 8:10 AM

Chardan Capital analyst Brian Dobson initiates coverage on Dragonfly Energy Hldgs (NASDAQ:DFLI) with a Buy rating and announces Price Target of $15.

DFLI

1 minute read

Piper Sandler Initiates Coverage On DraftKings with Overweight Rating, Announces Price Target of $21

By Benzinga Newsdesk

November 18, 6:06 AM

Piper Sandler analyst Matt Farrell initiates coverage on DraftKings (NASDAQ:DKNG) with a Overweight rating and announces Price Target of $21.

DKNG

1 minute read

Credit Suisse Initiates Coverage On Eli Lilly with Outperform Rating, Announces Price Target of $395

By Benzinga Newsdesk

November 18, 6:00 AM

Credit Suisse analyst Trung Huynh initiates coverage on Eli Lilly (NYSE:LLY) with a Outperform rating and announces Price Target of $395.

LLY

1 minute read

Credit Suisse Initiates Coverage On Pfizer with Outperform Rating, Announces Price Target of $55

By Benzinga Newsdesk

November 18, 5:58 AM

Credit Suisse analyst Trung Huynh initiates coverage on Pfizer (NYSE:PFE) with a Outperform rating and announces Price Target of $55.

PFE

1 minute read

Credit Suisse Initiates Coverage On Bristol-Myers Squibb with Neutral Rating, Announces Price Target of $78

By Benzinga Newsdesk

November 18, 5:56 AM

Credit Suisse analyst Trung Huynh initiates coverage on Bristol-Myers Squibb (NYSE:BMY) with a Neutral rating and announces Price Target of $78.

BMY

1 minute read

Credit Suisse Initiates Coverage On Merck & Co with Outperform Rating, Announces Price Target of $120

By Benzinga Newsdesk

November 18, 5:54 AM

Credit Suisse analyst Trung Huynh initiates coverage on Merck & Co (NYSE:MRK) with a Outperform rating and announces Price Target of $120.

MRK

1 minute read

Theratechnologies Is An Underappreciated HIV-Focused Company, Analyst Says

By Vandana Singh

November 17, 3:09 PM

Cantor Fitzgerald has initiated coverage on Theratechnologies Inc (NASDAQ:THTX) with an Overweight rating and a price target of $9. Theratechnologies’ two HIV…

THTX

1 minute read

This Rare Disease Focused Stock Pipeline Is Underappreciated, Analyst Initiating Coverage Says

By Vandana Singh

November 17, 3:05 PM

Cantor Fitzgerald has initiated coverage on KemPharm Inc (NASDAQ:KMPH) with an Overweight rating and a price target of $20. Per the analyst,…

KMPH

15 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For November 17, 2022

By Benzinga Insights

November 17, 11:13 AM

Upgrades

AAP

1 minute read

Keefe, Bruyette & Woods Initiates Coverage On Root with Market Perform Rating, Announces Price Target of $9

By Benzinga Newsdesk

November 17, 9:51 AM

Keefe, Bruyette & Woods analyst Thomas McJoynt-Griffith initiates coverage on Root (NASDAQ:ROOT) with a Market Perform rating and announces Price Target of $9.

ROOT